Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Ruesch Gerdes, S."'
Publikováno v:
In Journal of Dairy Science March 2015 98(3):1634-1639
Publikováno v:
In Respiratory Medicine November 2014 108(11):1677-1687
Publikováno v:
In Clinical Microbiology and Infection December 2007 13(12):1144-1156
Autor:
Nikolayevskyy, V., Hillemann, D., Richter, E., Ahmed, N., Werf, M.J. van der, Kodmon, C., Drobniewski, F., Ruesch-Gerdes, S., Soolingen, D. van
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 4, p e0152926 (2016)
PLoS One, 11
PLoS One, 11, 4
PLoS ONE, Vol 11, Iss 4, p e0152926 (2016)
PLoS One, 11
PLoS One, 11, 4
Background External quality assurance (EQA) systems are essential to ensure accurate diagnosis of TB and drug-resistant TB. The implementation of EQA through organising regular EQA rounds and identification of training needs is one of the key activit
Autor:
Migliori, G. B., Lange, C., Centis, R., Sotgiu, G., Mutterlein, R., Hoffmann, H., Kliiman, K., De Iaco, G., Lauria, F. N., Richardson, M. D., Spanevello, A., Cirillo, D. M., Ortmann, J., Kirsten, D., Ruesch Gerdes, S., Piana, F., Gori, A., Codecasa, L. R., Ferrarese, M., Toungoussova, O. S., Ferrara, Giovanni, Matteelli, A., De Lorenzo, S., Troupioti, P., Besozzi, G., Fattorini, L., Iona, E., Gualano, A., De Mori, P., Bevilacqua, N., Girardi, E., Danilovits, M., Hollo, V., Mariandyshev, A.
Publikováno v:
European Respiratory Journal. 31:1155-1159
No information is currently available on the influence of injectable second-line drugs on treatment outcomes of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) patients. To investigate this issue, a large series of MD
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sotgiu, G, Ferrara, Giovanni, Matteelli, A, Richardson, M, Centis, R, RUESCH GERDES, S, Toungoussova, O, Zellweger, J, Spanevello, A, Cirillo, D, Lange, C, Migliori, G.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3982::973f9c2ca1c52ad5b848b87fd1873dd3
http://hdl.handle.net/11391/126392
http://hdl.handle.net/11391/126392
Autor:
Eker, B, Ortmann, J, Migliori, GB, Sotgiu, G, Muetterlein, R, Centis, R, Hoffmann, H, Kirsten, D, Schaberg, T, Ruesch-Gerdes, S, Lange, C
Publikováno v:
Eker, B; Ortmann, J; Migliori, GB; Sotgiu, G; Muetterlein, R; Centis, R; Hoffmann, H; Kirsten, D; Schaberg, T; Ruesch-Gerdes, S; Lange, C (2008). Multidrug-and extensively drug-resistant tuberculosis. Emerging infectious diseases, 11(14), pp. 1700-1706. Atlanta, Ga.: U.S. National Center for Infectious Diseases 10.3201/eid1411.080729
We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in 2004–2006. In 177 (4%) of 4,557 culture-positive TB cases, Mycobacterium tuberculosis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3071::9e4a318e13a90b33de8feff1b6257253
https://boris.unibe.ch/30522/
https://boris.unibe.ch/30522/
Autor:
Migliori, G. B., Ortmann, J., Girardi, E., Besozzi, G., Lange, C., Cirillo, D. M., Ferrarese, M., De Iaco, G., Gori, A., Raviglione, M. C., Kirsten, D., Ruesch Gerdes, S., Piana, F., Codecasa, L. R., Lacchini, C., Matteelli, A., De Lorenzo, S., Troupioti, P., Gualano, G., De Mori, P., Fattorini, L., Iona, E., Ferrara, Giovanni, Centis, R.
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 13, Iss 5, Pp 780-782 (2007)
Emerging Infectious Diseases, Vol 13, Iss 5, Pp 780-782 (2007)
To the Editor: Twenty-three countries have reported >1 case of extensively drug-resistant tuberculosis (XDR TB) (1); however, information about XDR TB is still incomplete. In particular, the response of XDR TB to treatment in countries with low incid